Digest Network Come funziona
Network
/
Società
Ce
Non verificato

Cellares

Di cosa scriviamo

BiotecnologiaFarmaceuticaIndustriaMercato del lavoroSalute

20 comunicati stampa

Guarda tutti i comunicati
18/02/2026
Cellares and University of Wisconsin School of Medicine and Public Health Expand Partnership to Clinical Manufacturing of CRISPR-Edited CAR-T for Solid Tumors
Fonte
Cellares
Emittente
Business Wire
1.00
0
03/02/2026
Cellares to Expand Automated Manufacturing to Gene-Edited Stem Cell Therapies
Fonte
Cellares
Emittente
Business Wire
1.00
0
28/01/2026
Cellares Raises $257 Million Series D Led by BlackRock and Eclipse to Industrialize Global Cell Therapy Manufacturing with Breakthrough Automation
Fonte
Cellares
Emittente
Business Wire
1.00
0
12/01/2026
Mercato del lavoro
Industria
Biotecnologia
Sanità
Salute
Farmaceutica
Scienza
Cellares amplia la rete globale di Smart Factory con una sede centrale europea nei Paesi Bassi
Fonte
Cellares
Emittente
Business Wire
1.00
0
12/01/2026
Industria
Salute
Biotecnologia
Medicina - Varie
Scienza
Farmaceutica
IND Amendment Clearance Obtained for Clinical Manufacturing of Rese-Cel from Cabaletta Bio Using Cellares' Automated Platforms
Fonte
Cellares
Emittente
Business Wire
1.00
0
12/01/2026
Mercato del lavoro
Industria
Biotecnologia
Sanità
Salute
Farmaceutica
Scienza
Cellares Expands Global Smart Factory Network With European Headquarters in the Netherlands
Fonte
Cellares
Emittente
Business Wire
1.00
0
08/01/2026
Scienza
Sanità
Farmaceutica
Oncologia
Industria
Biotecnologia
Salute
Mercato del lavoro
Cellares and City of Hope to Automate Manufacturing of Solid Tumor CAR T Cell Therapy
Fonte
Cellares
Emittente
Business Wire
1.00
0
01/12/2025
Cellares Appoints Former MaxCyte Commercial Chief Ali Soleymannezhad as Chief Commercial Officer to Lead Global IDMO Expansion, Catalyze Next Wave of Partnerships, Prepare for IPO
Fonte
Cellares
Emittente
Business Wire
1.00
0
22/09/2025
Cellares Appoints Former Kite Global Ops Leader, Christopher McDonald, to Board of Advisors
Fonte
Cellares
Emittente
Business Wire
1.00
0
17/09/2025
Cellares Selects Five Best-in-Class Technology Providers, Tecan, Advanced Instruments, Cytek Biosciences, Slingshot Biosciences and AltemisLab, to Expand Cell Q’s Capabilities in Meeting Demands for Commercial Scale Cell Therapy Quality Control
Fonte
Cellares
Emittente
Business Wire
1.00
0

Recapiti

Social Media

Seguaci
0
Compatibilità
0